MDRX insider trading
OTC Markets OTCPK HealthcareVeradigm Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About Veradigm Inc.
Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to healthcare providers, comprising practice management software, AI patient scheduling software, and electronic statements and payments, and payerpath clearinghouse; revenue cycle services and coding services; electronic health records solutions, which include eprescribe with EPCS, EHR software, veradigm EHR, and practice fusion EHR; and patient engagement platform. It also provides solutions to network partners, which comprise API connectivity solutions, such as veradigm connect, veradigm app expo, and diagnostic ordering and resulting network; life sciences, health plans and payers, and providers; and veradigm eprescribe enterprise. In addition, the company offers risk adjustment solutions, such as health equity analytics, risk adjustment analytics, risk mitigator, comprehensive submissions, and utilization analytics; quality analytics, risk adjustment, and quality management; data exchange and coding solutions, including echart courier, echart coder, and echart integration and analytics; clinical data registries for physicians and veradigm payer insights; provider engagement solutions; care gap alerting, gap closure services, and veradigm payerpath solutions. Further, it provides real world data solutions, such as NLP-enriched EHR data solutions, and clinical data registries; real world evidence and real-world evidence analytics platform; and digital health media solutions. The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.
Company website: veradigm.com
MDRX insider activity at a glance
FilingIQ has scored 438 insider transactions for MDRX since Feb 25, 2014. The most recent filing in our index is dated May 10, 2026.
Across the full history, 20 open-market purchases
and 79 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on MDRX insider trades is 60.6/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for MDRX?
- FilingIQ tracks 438 Form 4 insider transactions for MDRX (Veradigm Inc.), covering filings from Feb 25, 2014 onwards. 5 of those were filed in the last 90 days.
- Are MDRX insiders net buyers or net sellers?
- Across the full Form 4 history for MDRX, 20 transactions (5%) were open-market purchases and 79 (18%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does MDRX insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is MDRX in?
- Veradigm Inc. (MDRX) is classified in the Healthcare sector, specifically Health Information Services, with a current market capitalisation of $516.19M.
Methodology & sources
Every MDRX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.